UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
Biogentech Corp.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
09063N 10 4
--------------------------------------------------------------------------------
(CUSIP Number)
Chaslav Radovich, 2445 McCabe Way, Suite 150, Irvine, CA 92614
(949) 757-0001
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
--------------------------------------------------------------------------------
November 26, 2003
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See ss.240.13d-7 for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 09063N 10 4
-----------------------
________________________________________________________________________________
1. Name of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Chaslav Radovich
________________________________________________________________________________
2. Check the Appropriate Box If a Member of a Group (See Instructions)
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC Use Only
________________________________________________________________________________
4. Source of Funds (See Instructions)
OO
________________________________________________________________________________
5. Check If Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e)
________________________________________________________________________________
6. Citizenship or Place of Organization
United States
________________________________________________________________________________
7. Sole Voting Power 306,200
NUMBER OF ---------
SHARES _________________________________________________________________
BENEFICIALLY 8. Shared Voting Power 11,750,000
OWNED BY ----------
EACH _________________________________________________________________
REPORTING 9. Sole Dispositive Power 306,200
PERSON ---------
WITH _________________________________________________________________
10. Shared Dispositive Power 11,750,000
----------
________________________________________________________________________________
11. Aggregate Amount Beneficially Owned by Each Reporting Person
12,056,200
________________________________________________________________________________
12. Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
________________________________________________________________________________
13. Percent of Class Represented by Amount in Row (11)
49.7%
________________________________________________________________________________
14. Type of Reporting Person (See Instructions)
IN
________________________________________________________________________________
ITEM 1. SECURITY AND ISSUER
---------------------------
This statement relates to shares of the common stock, $.001 par value of
Biogentech Corp., a Nevada corporation (the "Issuer"). The principal executive
offices of the Issuer are located at 2445 McCabe Way, Suite 150, Irvine, CA
92614.
ITEM 2. IDENTITY AND BACKGROUND
--------------------------------
(a) Name; Chaslav Radovich
(b) Business address; 2445 McCabe Way, Suite 150,
Irvine, CA 92614
(c) Present Principal Occupation: Sole officer and director of
the Issuer.
(d) Disclosure of Criminal Proceedings: none
(e) Disclosure of Civil Proceedings: none
(f) Citizenship. United States.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
---------------------------------------------------------
Chaslav Radovich, sole officer and director of the Issuer, acquired 306,200
shares of the Issuer's shares in exchange for his shares of Biogentech Inc. a
privately held Nevada corporation that is the Issuer's wholly owned subsidiary
on November 26, 2003 pursuant to a share exchange agreement. Mr. Radovich owns
262,200 shares of the Issuer's common stock directly and personally, and 44,000
shares as custodian for the benefit of his minor child, Milena Radovich.
ITEM 4. PURPOSE OF TRANSACTION
-------------------------------
Mr. Radovich acquired 360,200 shares in exchange for his shares of Biogentec
Inc., pursuant to the share exchange agreement dated March 31, 2003 by which the
Issuer acquired Biogentec Inc. as a wholly owned subsidiary. Mr. Radovich owns
262,200 shares of the Issuer's common stock directly and personally, and 44,000
shares as custodian for the benefit of his minor child, Milena Radovich.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
---------------------------------------------
Mr. Radovich beneficially owns a total of 12,056,200 shares of the Issuer's
common stock as follows:
(a) Chaslav Radovich, sole officer and director of the Issuer, owns 262,200
shares individually, and as custodian for his minor child Milena Radovich, who
owns 44,000 shares. The St. Petka Trust directly owns 11,750,000 shares of the
Issuer's common stock which comprises 44.8% of the Issuer's total issued and
outstanding shares. The beneficiaries of the St. Petka Trust are immediate
family members of Chaslav Radovich and Milena Radovich, and who share a
household with those beneficiaries of the St. Petka Trust.
(b) Chaslav Radovich has sole voting and dispostive power as to the 262,000
shares he owns individually and as to the 44,000 shares which he holds as
custodian for his minor child, Milena Radovich. The St. Petka Trust has sole
voting and dispositive power as to the 11,750,000 shares it owns directly.
(c) None.
(d) Not Applicable.
(e) Not Applicable.
ITEM 6. CONTACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
--------------------------
None.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
December 3, 2003
-----------------------------
Date
/s/ Chaslav Radovich
-----------------------------
Signature
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement: provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT
CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)